Xencor (XNCR) Current Leases (2013 - 2026)
Xencor's (XNCR) quarterly Current Leases came in at $4.0 million in Q1 2026, up 10.82% year-on-year from $3.6 million in Q1 2025, and up 23.63% on a QoQ basis from $3.3 million in Q4 2025.
Xencor (XNCR) Current Leases (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 10 years of Current Leases data on file, last reported at $4.0 million in Q1 2026.
- On a quarterly basis, Current Leases rose 10.82% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 10.82% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 8.44% from the prior year.
- Current Leases for Q1 2026 stood at $4.0 million, up from $3.3 million in the prior quarter.
- Over the last five years, Current Leases for XNCR reached as high as $20.6 million in Q3 2022 and fell as low as $936000.0 in Q1 2022.
- Historically, Current Leases has averaged $4.5 million across 5 years, with a median of $3.6 million in 2025.
- Across the five-year window, Current Leases soared 15955.47% in 2022 and tumbled 78.69% in 2023, its largest moves.
- Year by year, Current Leases stood at $4.7 million in 2022, then decreased by 27.04% to $3.4 million in 2023, then dropped by 12.4% to $3.0 million in 2024, then advanced by 8.44% to $3.3 million in 2025, then advanced by 23.63% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $4.0 million in Q1 2026, $3.3 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.03 Mn |
| Dec 31, 2025 | 3.26 Mn |
| Sep 30, 2025 | 3.94 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 20.55 Mn |
| Jun 30, 2022 | 7.65 Mn |
| Mar 31, 2022 | 936,000.00 |
| Sep 30, 2021 | 128,000.00 |
| Jun 30, 2021 | 2.32 Mn |
| Mar 31, 2021 | 1.93 Mn |